Home › NDC Lookup › Ingredients › Butalbital And Acetaminophen
📦 NDC / package directory — not a drug information page

Butalbital And Acetaminophen NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Butalbital And Acetaminophen products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

21
Package NDCs
16
Products
16
Active listings
0
Discontinued
10
Labelers
6
Strengths
2
Dosage forms
8
With NADAC pricing

By strength, form & labeler

NDC products by strength
BUTALBITAL 50 mg/1; ACETAMINOPHEN... 6
BUTALBITAL 50 mg/1; ACETAMINOPHEN... 4
ACETAMINOPHEN 300 mg/1; BUTALBITAL... 2
BUTALBITAL 25 mg/1; ACETAMINOPHEN... 2
ACETAMINOPHEN 325 mg/1; BUTALBITAL... 1
ACETAMINOPHEN 325 mg/1; BUTALBITAL... 1
By dosage form
TABLET 14
CAPSULE 2
Top labelers
Amici Pharma, Inc. 3
Larken Laboratories, Inc. 3
Burel Pharmaceuticals, LLC 2
QUAGEN PHARMACEUTICALS LLC 2
Aarkish Pharmaceuticals NJ Inc. 1
Dr. Reddy's Labratories Inc. 1
El Dorado Distributors LLC 1
Endo USA 1

Browse records — 16 products

Drug / product Billing NDC NADAC / unit Status
ALLZITAL butalbital and acetaminophen 25 mg/1; 325 mg/1 TABLET Larken · NDC 68047-0752-01 · 100 TABLET in 1 BOTTLE (68047-752-01) 68047-0752-01 — On market View →
butalbital and acetaminophen 50 mg/1; 300 mg/1 CAPSULE Granules · NDC 70010-0054-01 · 100 CAPSULE in 1 BOTTLE (70010-054-01) 70010-0054-01 — On market View →
BUTALBITAL AND ACETAMINOPHEN 300 mg/1; 50 mg/1 TABLET Aarkish · NDC 81005-0123-01 · 100 TABLET in 1 BOTTLE (81005-123-01) 81005-0123-01 — On market View →
butalbital and acetaminophen 50 mg/1; 325 mg/1 TABLET Par · NDC 00603-2540-21 · 100 TABLET in 1 BOTTLE (0603-2540-21) 00603-2540-21 $0.589 /unit · NADAC On market View →
BUTALBITAL AND ACETAMINOPHEN 50 mg/1; 300 mg/1 TABLET Burel · NDC 35573-0455-02 · 100 TABLET in 1 BOTTLE (35573-455-02) 35573-0455-02 $1.532 /unit · NADAC On market View →
BUTALBITAL AND ACETAMINOPHEN 325 mg/1; 25 mg/1 TABLET Amici · NDC 69292-0303-01 · 100 TABLET in 1 BOTTLE (69292-303-01) 69292-0303-01 — On market View →
BUTALBITAL and ACETAMINOPHEN 50 mg/1; 300 mg/1 TABLET QUAGEN · NDC 70752-0147-10 · 100 TABLET in 1 BOTTLE, PLASTIC (70752-147-10) 70752-0147-10 $1.532 /unit · NADAC On market View →
BUTALBITAL AND ACETAMINOPHEN 50 mg/1; 325 mg/1 TABLET Burel · NDC 35573-0456-02 · 100 TABLET in 1 BOTTLE (35573-456-02) 35573-0456-02 $0.589 /unit · NADAC On market View →
BUTALBITAL AND ACETAMINOPHEN 325 mg/1; 50 mg/1 TABLET Amici · NDC 69292-0302-01 · 100 TABLET in 1 BOTTLE (69292-302-01) 69292-0302-01 $0.589 /unit · NADAC On market View →
Butalbital And Acetaminophen 50 mg/1; 325 mg/1 TABLET Larken · NDC 68047-0721-01 · 100 TABLET in 1 BOTTLE (68047-721-01) 68047-0721-01 $0.589 /unit · NADAC On market View →
butalbital and acetaminophen 50 mg/1; 300 mg/1 CAPSULE Dr. · NDC 75907-0008-01 · 100 CAPSULE in 1 BOTTLE (75907-008-01) 75907-0008-01 — On market View →
Butalbital and Acetaminophen 25 mg/1; 325 mg/1 TABLET Larken · NDC 68047-0753-01 · 100 TABLET in 1 BOTTLE (68047-753-01) 68047-0753-01 — On market View →
BUTALBITAL and ACETAMINOPHEN 50 mg/1; 325 mg/1 TABLET QUAGEN · NDC 70752-0148-10 · 100 TABLET in 1 BOTTLE (70752-148-10) 70752-0148-10 $0.589 /unit · NADAC On market View →
BUTALBITAL AND ACETAMINOPHEN 300 mg/1; 50 mg/1 TABLET Amici · NDC 69292-0301-01 · 100 TABLET in 1 BOTTLE (69292-301-01) 69292-0301-01 — On market View →
butalbital and acetaminophen 50 mg/1; 325 mg/1 TABLET Par · NDC 00603-2540-21 · 100 TABLET in 1 BOTTLE (0603-2540-21) 00603-2540-21 $0.589 /unit · NADAC On market View →
Tencon butalbital and acetaminophen 50 mg/1; 325 mg/1 TABLET El · NDC 11584-0030-01 · 100 TABLET in 1 BOTTLE, PLASTIC (11584-0030-1) 11584-0030-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.